US Stock MarketDetailed Quotes

RYTM Rhythm Pharmaceuticals

Watchlist
  • 40.810
  • 0.0000.00%
Close Jul 3 13:00 ET
2.49BMarket Cap-8814P/E (TTM)

Rhythm Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-11.83%-40.74M
21.49%-136.16M
13.58%-29.38M
37.75%-29.25M
-5.88%-41.09M
32.07%-36.43M
-18.78%-173.43M
15.99%-34M
-17.00%-46.99M
-21.89%-38.81M
Net income from continuing operations
-170.94%-141.37M
-1.97%-184.68M
2.02%-41.63M
-8.08%-44.16M
-3.78%-46.7M
1.11%-52.18M
-160.18%-181.12M
0.87%-42.49M
-16.39%-40.86M
-27.16%-45M
Operating gains losses
-880.00%-490K
-124.05%-190K
84.00%-40K
---130K
--30K
---50K
100.79%790K
---250K
----
----
Depreciation and amortization
-11.38%405K
5.14%1.76M
-5.66%417K
0.00%442K
0.91%442K
30.57%457K
44.39%1.67M
36.00%442K
40.32%442K
38.17%438K
Other non cash items
1,039.58%97.43M
279.30%19.43M
31.79%4.13M
57.37%3.27M
18,447.37%3.49M
13,253.85%8.55M
2,148.80%5.12M
4,915.38%3.13M
3,395.24%2.08M
68.85%-19K
Change In working capital
-179.45%-2.19M
127.61%4.81M
305.32%8.91M
119.52%2.83M
-1,622.33%-9.68M
147.78%2.75M
-1,017.76%-17.41M
-59.65%2.2M
-817.62%-14.48M
-75.96%636K
-Change in receivables
109.09%172K
-66.24%-8.64M
94.72%-178K
-591.94%-858K
-235.13%-5.71M
---1.89M
-315.92%-5.2M
-169.60%-3.37M
---124K
---1.71M
-Change in inventory
104.55%117K
-103.39%-5.71M
29.98%-862K
-31,800.00%-1.59M
56.33%-690K
---2.57M
-25,409.09%-2.81M
---1.23M
--5K
---1.58M
-Change in prepaid assets
-212.34%-2.42M
477.51%2.88M
327.17%5.24M
392.08%497K
-385.98%-5.02M
126.84%2.16M
114.91%498K
53.18%-2.31M
-96.59%101K
158.02%1.76M
-Change in payables and accrued expense
-124.21%-1.25M
857.42%14.77M
-69.08%4.86M
132.52%4.09M
142.73%661K
9,849.06%5.17M
-91.57%1.54M
21.61%15.71M
-309.83%-12.57M
-127.28%-1.55M
-Change in other current assets
1,307.07%1.2M
134.21%1.66M
-500.00%-4K
161.72%537K
-54.57%1.22M
98.51%-99K
59.04%-4.84M
100.08%1K
91.74%-870K
--2.69M
-Change in other working capital
----
97.76%-148K
----
----
---142K
---6K
---6.61M
----
----
----
Cash from discontinued investing activities
Operating cash flow
-11.83%-40.74M
21.49%-136.16M
13.58%-29.38M
37.75%-29.25M
-5.88%-41.09M
32.07%-36.43M
-18.78%-173.43M
15.99%-34M
-17.00%-46.99M
-21.89%-38.81M
Investing cash flow
Cash flow from continuing investing activities
62.75%30.05M
-120.21%-5.67M
155.52%22.64M
-139.21%-94.96M
33.94%48.19M
-74.54%18.46M
145.09%28.03M
-662.57%-40.78M
-163.23%-39.7M
166.02%35.98M
Net PPE purchase and sale
--0
83.27%-47K
0.00%1K
98.95%-1K
--0
62.99%-47K
35.25%-281K
101.47%1K
10.38%-95K
75.81%-60K
Net intangibles purchase and sale
----
--0
--0
--0
----
----
-300.00%-4M
--0
--0
----
Net business purchase and sale
----
--0
----
----
----
----
--0
----
----
----
Net investment purchase and sale
204.16%70.05M
-99.85%49K
155.52%22.64M
-139.10%-94.69M
22.55%49.07M
-68.30%23.03M
119.73%32.31M
-13,003.80%-40.78M
-162.97%-39.6M
113.28%40.04M
Net other investing changes
-784.96%-40M
---5.67M
--0
---272K
---875K
---4.52M
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
62.75%30.05M
-120.21%-5.67M
155.52%22.64M
-139.21%-94.96M
33.94%48.19M
-74.54%18.46M
145.09%28.03M
-662.57%-40.78M
-163.23%-39.7M
166.02%35.98M
Financing cash flow
Cash flow from continuing financing activities
3,290.23%4.24M
-65.22%74.37M
-86.05%2.42M
-53.93%73.04M
-102.57%-965K
-133.33%-133K
28.44%213.83M
17,265.00%17.37M
38,293.22%158.56M
9,691.12%37.5M
Net common stock issuance
----
-62.72%48.88M
--0
----
----
----
-18.93%131.11M
282,860.00%14.14M
----
----
Proceeds from stock option exercised by employees
476.85%7.03M
-17.89%8.52M
-15.15%5M
-51.96%1.97M
--341K
205.26%1.22M
118.25%10.38M
5,508.57%5.89M
890.31%4.09M
--0
Net other financing activities
-106.00%-2.78M
-76.54%16.97M
3.31%-2.57M
-40.79%22.2M
---1.31M
---1.35M
--72.34M
---2.66M
--37.5M
----
Cash from discontinued financing activities
Financing cash flow
3,290.23%4.24M
-65.22%74.37M
-86.05%2.42M
-53.93%73.04M
-102.57%-965K
-133.33%-133K
28.44%213.83M
17,265.00%17.37M
38,293.22%158.56M
9,691.12%37.5M
Net cash flow
Beginning cash position
-52.81%60.41M
114.86%128.01M
-64.99%64.92M
2.18%116.01M
39.46%109.99M
114.86%128.01M
-41.16%59.58M
100.02%185.42M
62.97%113.54M
-9.97%78.87M
Current changes in cash
64.37%-6.45M
-198.58%-67.45M
92.48%-4.32M
-171.19%-51.17M
-82.30%6.14M
-193.85%-18.1M
264.17%68.43M
-73.32%-57.41M
212.07%71.88M
293.34%34.67M
Effect of exchange rate changes
-182.56%-71K
---142K
---192K
--77K
---113K
--86K
--0
--0
--0
--0
End cash Position
-51.01%53.89M
-52.81%60.41M
-52.81%60.41M
-64.99%64.92M
2.18%116.01M
39.46%109.99M
114.86%128.01M
114.86%128.01M
100.02%185.42M
62.97%113.54M
Free cash flow
-11.69%-40.74M
23.36%-136.2M
13.58%-29.38M
37.87%-29.25M
4.15%-41.09M
32.14%-36.48M
-17.35%-177.71M
16.13%-34M
-16.93%-47.08M
-15.59%-42.87M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -11.83%-40.74M21.49%-136.16M13.58%-29.38M37.75%-29.25M-5.88%-41.09M32.07%-36.43M-18.78%-173.43M15.99%-34M-17.00%-46.99M-21.89%-38.81M
Net income from continuing operations -170.94%-141.37M-1.97%-184.68M2.02%-41.63M-8.08%-44.16M-3.78%-46.7M1.11%-52.18M-160.18%-181.12M0.87%-42.49M-16.39%-40.86M-27.16%-45M
Operating gains losses -880.00%-490K-124.05%-190K84.00%-40K---130K--30K---50K100.79%790K---250K--------
Depreciation and amortization -11.38%405K5.14%1.76M-5.66%417K0.00%442K0.91%442K30.57%457K44.39%1.67M36.00%442K40.32%442K38.17%438K
Other non cash items 1,039.58%97.43M279.30%19.43M31.79%4.13M57.37%3.27M18,447.37%3.49M13,253.85%8.55M2,148.80%5.12M4,915.38%3.13M3,395.24%2.08M68.85%-19K
Change In working capital -179.45%-2.19M127.61%4.81M305.32%8.91M119.52%2.83M-1,622.33%-9.68M147.78%2.75M-1,017.76%-17.41M-59.65%2.2M-817.62%-14.48M-75.96%636K
-Change in receivables 109.09%172K-66.24%-8.64M94.72%-178K-591.94%-858K-235.13%-5.71M---1.89M-315.92%-5.2M-169.60%-3.37M---124K---1.71M
-Change in inventory 104.55%117K-103.39%-5.71M29.98%-862K-31,800.00%-1.59M56.33%-690K---2.57M-25,409.09%-2.81M---1.23M--5K---1.58M
-Change in prepaid assets -212.34%-2.42M477.51%2.88M327.17%5.24M392.08%497K-385.98%-5.02M126.84%2.16M114.91%498K53.18%-2.31M-96.59%101K158.02%1.76M
-Change in payables and accrued expense -124.21%-1.25M857.42%14.77M-69.08%4.86M132.52%4.09M142.73%661K9,849.06%5.17M-91.57%1.54M21.61%15.71M-309.83%-12.57M-127.28%-1.55M
-Change in other current assets 1,307.07%1.2M134.21%1.66M-500.00%-4K161.72%537K-54.57%1.22M98.51%-99K59.04%-4.84M100.08%1K91.74%-870K--2.69M
-Change in other working capital ----97.76%-148K-----------142K---6K---6.61M------------
Cash from discontinued investing activities
Operating cash flow -11.83%-40.74M21.49%-136.16M13.58%-29.38M37.75%-29.25M-5.88%-41.09M32.07%-36.43M-18.78%-173.43M15.99%-34M-17.00%-46.99M-21.89%-38.81M
Investing cash flow
Cash flow from continuing investing activities 62.75%30.05M-120.21%-5.67M155.52%22.64M-139.21%-94.96M33.94%48.19M-74.54%18.46M145.09%28.03M-662.57%-40.78M-163.23%-39.7M166.02%35.98M
Net PPE purchase and sale --083.27%-47K0.00%1K98.95%-1K--062.99%-47K35.25%-281K101.47%1K10.38%-95K75.81%-60K
Net intangibles purchase and sale ------0--0--0---------300.00%-4M--0--0----
Net business purchase and sale ------0------------------0------------
Net investment purchase and sale 204.16%70.05M-99.85%49K155.52%22.64M-139.10%-94.69M22.55%49.07M-68.30%23.03M119.73%32.31M-13,003.80%-40.78M-162.97%-39.6M113.28%40.04M
Net other investing changes -784.96%-40M---5.67M--0---272K---875K---4.52M----------------
Cash from discontinued investing activities
Investing cash flow 62.75%30.05M-120.21%-5.67M155.52%22.64M-139.21%-94.96M33.94%48.19M-74.54%18.46M145.09%28.03M-662.57%-40.78M-163.23%-39.7M166.02%35.98M
Financing cash flow
Cash flow from continuing financing activities 3,290.23%4.24M-65.22%74.37M-86.05%2.42M-53.93%73.04M-102.57%-965K-133.33%-133K28.44%213.83M17,265.00%17.37M38,293.22%158.56M9,691.12%37.5M
Net common stock issuance -----62.72%48.88M--0-------------18.93%131.11M282,860.00%14.14M--------
Proceeds from stock option exercised by employees 476.85%7.03M-17.89%8.52M-15.15%5M-51.96%1.97M--341K205.26%1.22M118.25%10.38M5,508.57%5.89M890.31%4.09M--0
Net other financing activities -106.00%-2.78M-76.54%16.97M3.31%-2.57M-40.79%22.2M---1.31M---1.35M--72.34M---2.66M--37.5M----
Cash from discontinued financing activities
Financing cash flow 3,290.23%4.24M-65.22%74.37M-86.05%2.42M-53.93%73.04M-102.57%-965K-133.33%-133K28.44%213.83M17,265.00%17.37M38,293.22%158.56M9,691.12%37.5M
Net cash flow
Beginning cash position -52.81%60.41M114.86%128.01M-64.99%64.92M2.18%116.01M39.46%109.99M114.86%128.01M-41.16%59.58M100.02%185.42M62.97%113.54M-9.97%78.87M
Current changes in cash 64.37%-6.45M-198.58%-67.45M92.48%-4.32M-171.19%-51.17M-82.30%6.14M-193.85%-18.1M264.17%68.43M-73.32%-57.41M212.07%71.88M293.34%34.67M
Effect of exchange rate changes -182.56%-71K---142K---192K--77K---113K--86K--0--0--0--0
End cash Position -51.01%53.89M-52.81%60.41M-52.81%60.41M-64.99%64.92M2.18%116.01M39.46%109.99M114.86%128.01M114.86%128.01M100.02%185.42M62.97%113.54M
Free cash flow -11.69%-40.74M23.36%-136.2M13.58%-29.38M37.87%-29.25M4.15%-41.09M32.14%-36.48M-17.35%-177.71M16.13%-34M-16.93%-47.08M-15.59%-42.87M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg